This paper examines the impact of Regulation (EU) N. 327/2025 establishing the European Health Data Space (EHDS), focusing on its principal innovations and the critical issues it raises in relation to the GDPR and the Italian legal framework. It analyses the rules governing the primary use of electronic health data, which are intended to facilitate crossborder healthcare by ensuring patients immediate, free of charge, and portable access to their electronic health records. It further examines the framework governing the secondary use of health data, designed to promote scientific research, pharmaceutical innovation, and the development of artificial intelligence systems through the establishment and use of large-scale, centralised datasets. The core of the analysis concerns the fundamental paradigm shift introduced by the EHDS: the move away from a model based on the data subject’s prior consent (opt-in) towards a framework grounded in the public interest, under which health data may be made available through public channels without prior consent, subject to the individual’s subsequent right to object (opt-out). The paper finally identifies a number of critical aspects of the reform, including the risk of fragmentation arising from national derogations from the opt-out mechanism, as well as the concerns raised by Article 1(8), which permits private contractual arrangements and may consequently contribute to the emergence of a two-tier system, potentially undermining the uniformity of patient protection and the individual’s control over health data.
Faillace, S. (2026). Annotazioni critiche sul regolamento europeo in tema di spazi di dati sanitari (EHDS). CONTRATTO E IMPRESA EUROPA, 2(2), 455-483.
Annotazioni critiche sul regolamento europeo in tema di spazi di dati sanitari (EHDS)
Stefano Faillace
2026
Abstract
This paper examines the impact of Regulation (EU) N. 327/2025 establishing the European Health Data Space (EHDS), focusing on its principal innovations and the critical issues it raises in relation to the GDPR and the Italian legal framework. It analyses the rules governing the primary use of electronic health data, which are intended to facilitate crossborder healthcare by ensuring patients immediate, free of charge, and portable access to their electronic health records. It further examines the framework governing the secondary use of health data, designed to promote scientific research, pharmaceutical innovation, and the development of artificial intelligence systems through the establishment and use of large-scale, centralised datasets. The core of the analysis concerns the fundamental paradigm shift introduced by the EHDS: the move away from a model based on the data subject’s prior consent (opt-in) towards a framework grounded in the public interest, under which health data may be made available through public channels without prior consent, subject to the individual’s subsequent right to object (opt-out). The paper finally identifies a number of critical aspects of the reform, including the risk of fragmentation arising from national derogations from the opt-out mechanism, as well as the concerns raised by Article 1(8), which permits private contractual arrangements and may consequently contribute to the emergence of a two-tier system, potentially undermining the uniformity of patient protection and the individual’s control over health data.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



